scholarly journals Differential Impact of Unilateral and Bilateral Classifications of Diabetic Retinopathy and Diabetic Macular Edema on Vision-Related Quality of Life

2016 ◽  
Vol 57 (11) ◽  
pp. 4655 ◽  
Author(s):  
Ryan Eyn Kidd Man ◽  
Eva K. Fenwick ◽  
Charumathi Sabanayagam ◽  
Ling-Jun Li ◽  
Ching Siong Tey ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Diabetic Retinopathy ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Differential Impact ◽  
Related Quality

scholarly journals The Effect of Ranibizumab Loading Treatment on Vision-Related Quality of Life in Diabetic Macular Edema

2021 ◽  
Vol 11 (3) ◽  
pp. 659-670
Author(s):  
Hatice Daldal ◽  
Mustafa Turkyilmaz ◽  
Melike Balikoglu Yilmaz ◽  
Ufuk Berberoglu
Keyword(s):  
Quality Of Life ◽  
Macular Edema ◽  
Intravitreal Injection ◽  
Diabetic Macular Edema ◽  
Macular Thickness ◽  
Loading Dose ◽  
The Third ◽  
Related Quality ◽  
Composite Scores

Aims: To investigate the changes in vision-related quality of life after a loading dose of three consecutive intravitreal ranibizumab (IVR) injections in patients with unilateral diabetic macular edema (DME). Materials and Methods: Fifty-two eyes of 52 patients who received IVR injections in only one eye with DME were included in our study. The following characteristics of the patients were recorded: gender, education status, marital status, work status, presence of chronic disease. The changes in best-corrected visual acuity (BCVA) and central macular thickness (CMT) were evaluated at baseline (before treatment) and 1 month after the third intravitreal injection (after treatment). Patients were administered the Turkish form of the National Eye Institute 25-Item Visual Functions Questionnaire (NEI VFQ-25 TR). The quality of life scores assessed by the NEI VFQ-25 TR, the BCVA, intraocular pressure (IOP), and CMT measurements were compared at baseline (before treatment) and 1 month after the third intravitreal injection (after treatment). Results: We enrolled 52 patients (25 females, 27 males) in our study; mean age was 64.35 ± 9.26 years. After treatment, BCVA improved significantly (p = 0.001), and macular thickness decreased significantly (p < 0.001). All NEI VFQ-25 TR subscale scores were significantly higher after treatment (p < 0.05). However, no significant correlation was found between the change in BCVA and CMT and the change in NEI VFQ-25 TR subscale and composite scores. The increase in near activities scores was significantly higher in males (p = 0.020) and in the retired group (p = 0.022). There were no significant differences in the changes in NEI VFQ-25 TR subscale and composite scores in relation to educational status. Discussion: Significant improvements in BCVA, macular edema, and vision-related quality of life were found in DME patients who received IVR injections with a loading dose, as shown by the NEI VFQ-25 TR. Interestingly, a significant improvement in quality of life was observed even though the patients could see well with the fellow eye. In conclusion, the NEI VFQ-25 TR is a useful scale to evaluate the changes in visual function and psychosocial characteristics of DME patients after treatment.

scholarly journals Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept

2019 ◽  
Vol 3 (7) ◽  
pp. 567-575 ◽  
Author(s):  
Justus G. Garweg ◽  
Jana Stefanickova ◽  
Carel Hoyng ◽  
Thomas Schmelter ◽  
Tobias Niesen ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Intravitreal Aflibercept ◽  
Related Quality

scholarly journals Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY)

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
John R. Gonder ◽  
Valery M. Walker ◽  
Martin Barbeau ◽  
Nancy Zaour ◽  
Bryan H. Zachau ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Visual Acuity ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Severe Loss ◽  
Telephone Interviews ◽  
Related Quality ◽  
Visual Acuity Loss ◽  
Composite Scores

Purpose. To characterize the economic and quality of life burden of diabetic macular edema (DME) in Canadian patients.Patients and Methods. 145 patients with DME were followed for 6 months with monthly telephone interviews and medical chart reviews at months 0, 3, and 6. Visual acuity in the worst-seeing eye was assessed at months 0 and 6. DME-related healthcare costs were determined over 6 months, and vision-related (National Eye Institute Visual Functioning Questionnaire) and generic (EQ-5D) quality of life was assessed at months 0, 3, and 6.Results. Mean age of patients was 63.7 years: 52% were male and 72% had bilateral DME. At baseline, visual acuity was categorized as normal/mild loss for 63.4% of patients, moderate loss for 10.4%, and severe loss/nearly blind for 26.2%. Mean 6-month DME-related costs/patient were as follows: all patients (n=135), $2,092; normal/mild loss (n=88), $1,776; moderate loss (n=13), $1,845; and severe loss/nearly blind (n=34), $3,007. Composite scores for vision-related quality of life declined with increasing visual acuity loss; generic quality of life scores were highest for moderate loss and lowest for severe loss/nearly blind.Conclusions. DME-related costs in the Canadian healthcare system are substantial. Costs increased and vision-related quality of life declined with increasing visual acuity severity.

scholarly journals PSS5 - VISION-RELATED QUALITY OF LIFE IN PATIENTS WITH DIABETIC MACULAR EDEMA TREATED WITH INTRAVITREAL AFLIBERCEPT: THE AQUA STUDY

2018 ◽  
Vol 21 ◽  
pp. S422-S423 ◽  
Author(s):  
J.G. Garweg ◽  
J. Stefanickova ◽  
C. Hoyng ◽  
T. Schmelter ◽  
T. Niesen ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Macular Edema ◽  
Diabetic Macular Edema ◽  
Intravitreal Aflibercept ◽  
Related Quality

Changes in vision related quality of life in patients with diabetic macular edema: Ranibizumab or laser treatment?

2015 ◽  
Vol 29 (4) ◽  
pp. 540-543 ◽  
Author(s):  
Elif Betul Turkoglu ◽  
Erkan Celık ◽  
Nilgun Aksoy ◽  
Ozlem Bursalı ◽  
Turgay Ucak ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Macular Edema ◽  
Laser Treatment ◽  
Diabetic Macular Edema ◽  
Related Quality

Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life

2017 ◽  
Vol 26 (7) ◽  
pp. 1767-1775 ◽  
Author(s):  
Benjamin Chaigne ◽  
◽  
Axel Finckh ◽  
Deshire Alpizar-Rodriguez ◽  
Delphine Courvoisier ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Rheumatoid Arthritis ◽  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Health Related Quality ◽  
Systemic Lupus ◽  
Differential Impact ◽  
Related Quality ◽  
Health Related
Sign in / Sign up

Export Citation Format

Share Document